BridgeBio Oncology Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBOT and other ETFs, options, and stocks.About BBOT
Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies.
BBOT Key Statistics
Stock Snapshot
The current BridgeBio Oncology Therapeutics(BBOT) stock price is $8.27, with a market capitalization of 660.93M. The stock trades at a price-to-earnings (P/E) ratio of -5.53.
As of 2026-05-06, BridgeBio Oncology Therapeutics(BBOT) stock has fluctuated between $8.15 and $8.67. The current price stands at $8.27, placing the stock +1.5% above today's low and -4.6% off the high.
BridgeBio Oncology Therapeutics(BBOT) shares are trading with a volume of 172.7K, against a daily average of 408.64K.
In the last year, BridgeBio Oncology Therapeutics(BBOT) shares hit a 52-week high of $14.87 and a 52-week low of $8.00.
In the last year, BridgeBio Oncology Therapeutics(BBOT) shares hit a 52-week high of $14.87 and a 52-week low of $8.00.
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.